170 related articles for article (PubMed ID: 9697834)
1. Self-reactive B lymphocytes overexpressing Bcl-xL escape negative selection and are tolerized by clonal anergy and receptor editing.
Fang W; Weintraub BC; Dunlap B; Garside P; Pape KA; Jenkins MK; Goodnow CC; Mueller DL; Behrens TW
Immunity; 1998 Jul; 9(1):35-45. PubMed ID: 9697834
[TBL] [Abstract][Full Text] [Related]
2. Reduced life span of anergic self-reactive B cells in a double-transgenic model.
Fulcher DA; Basten A
J Exp Med; 1994 Jan; 179(1):125-34. PubMed ID: 8270860
[TBL] [Abstract][Full Text] [Related]
3. In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance.
Hippen KL; Schram BR; Tze LE; Pape KA; Jenkins MK; Behrens TW
J Immunol; 2005 Jul; 175(2):909-16. PubMed ID: 16002689
[TBL] [Abstract][Full Text] [Related]
4. Ig light chain receptor editing in anergic B cells.
Tze LE; Baness EA; Hippen KL; Behrens TW
J Immunol; 2000 Dec; 165(12):6796-802. PubMed ID: 11120801
[TBL] [Abstract][Full Text] [Related]
5. Anergic B cells constitutively present self antigen: enhanced immunoglobulin receptor-mediated presentation of antigenic determinants by B cells is hierarchical.
Kanost D; McCluskey J
Eur J Immunol; 1994 May; 24(5):1186-93. PubMed ID: 7514133
[TBL] [Abstract][Full Text] [Related]
6. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help.
Fulcher DA; Lyons AB; Korn SL; Cook MC; Koleda C; Parish C; Fazekas de St Groth B; Basten A
J Exp Med; 1996 May; 183(5):2313-28. PubMed ID: 8642340
[TBL] [Abstract][Full Text] [Related]
7. Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells.
Lang J; Arnold B; Hammerling G; Harris AW; Korsmeyer S; Russell D; Strasser A; Nemazee D
J Exp Med; 1997 Nov; 186(9):1513-22. PubMed ID: 9348309
[TBL] [Abstract][Full Text] [Related]
8. Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors.
Kenny JJ; Rezanka LJ; Lustig A; Fischer RT; Yoder J; Marshall S; Longo DL
J Immunol; 2000 Apr; 164(8):4111-9. PubMed ID: 10754305
[TBL] [Abstract][Full Text] [Related]
9. Constitutive expression of Bcl-xL or Bcl-2 prevents peptide antigen-induced T cell deletion but does not influence T cell homeostasis after a viral infection.
Petschner F; Zimmerman C; Strasser A; Grillot D; Nunez G; Pircher H
Eur J Immunol; 1998 Feb; 28(2):560-9. PubMed ID: 9521066
[TBL] [Abstract][Full Text] [Related]
10. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes.
Bouillet P; Purton JF; Godfrey DI; Zhang LC; Coultas L; Puthalakath H; Pellegrini M; Cory S; Adams JM; Strasser A
Nature; 2002 Feb; 415(6874):922-6. PubMed ID: 11859372
[TBL] [Abstract][Full Text] [Related]
11. Enforced expression of the apoptosis inhibitor Bcl-2 ablates tolerance induction in DNA-reactive B cells through a novel mechanism.
Wang YH; Yan Y; Rice JS; Volpe BT; Diamond B
J Autoimmun; 2011 Aug; 37(1):18-27. PubMed ID: 21458954
[TBL] [Abstract][Full Text] [Related]
12. B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells.
Phan TG; Amesbury M; Gardam S; Crosbie J; Hasbold J; Hodgkin PD; Basten A; Brink R
J Exp Med; 2003 Apr; 197(7):845-60. PubMed ID: 12668643
[TBL] [Abstract][Full Text] [Related]
13. Development of myelin oligodendrocyte glycoprotein autoreactive transgenic B lymphocytes: receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein.
Litzenburger T; Blüthmann H; Morales P; Pham-Dinh D; Dautigny A; Wekerle H; Iglesias A
J Immunol; 2000 Nov; 165(9):5360-6. PubMed ID: 11046072
[TBL] [Abstract][Full Text] [Related]
14. Chronic GVH prevents anergy in bone marrow self-reactive B cells: a selective increase in post-endoplasmic reticulum processing and trafficking to the cell surface of autoreactive IgM receptors.
Feuerstein N; Shivers D; Chen F; Eisenberg RA; Finkel TH
Int Immunol; 2003 Aug; 15(8):975-85. PubMed ID: 12882835
[TBL] [Abstract][Full Text] [Related]
15. The origin of anti-nuclear antibodies in bcl-2 transgenic mice.
Mandik-Nayak L; Nayak S; Sokol C; Eaton-Bassiri A; Madaio MP; Caton AJ; Erikson J
Int Immunol; 2000 Mar; 12(3):353-64. PubMed ID: 10700470
[TBL] [Abstract][Full Text] [Related]
16. Outer periarteriolar lymphoid sheath arrest and subsequent differentiation of both naive and tolerant immunoglobulin transgenic B cells is determined by B cell receptor occupancy.
Cook MC; Basten A; Fazekas de St Groth B
J Exp Med; 1997 Aug; 186(5):631-43. PubMed ID: 9271579
[TBL] [Abstract][Full Text] [Related]
17. Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice.
Grillot DA; Merino R; Núñez G
J Exp Med; 1995 Dec; 182(6):1973-83. PubMed ID: 7500043
[TBL] [Abstract][Full Text] [Related]
18. Whither the anergic B-cell?
Fulcher DA; Basten A
Autoimmunity; 1994; 19(2):135-40. PubMed ID: 7772703
[TBL] [Abstract][Full Text] [Related]
19. Expression of a bcl-2 transgene reduces proliferation and slows turnover of developing B lymphocytes in vivo.
O'Reilly LA; Harris AW; Tarlinton DM; Corcoran LM; Strasser A
J Immunol; 1997 Sep; 159(5):2301-11. PubMed ID: 9278319
[TBL] [Abstract][Full Text] [Related]
20. Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model.
Chackerian B; Durfee MR; Schiller JT
J Immunol; 2008 May; 180(9):5816-25. PubMed ID: 18424700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
